| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.96e-07 | 18 | 153 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.50e-07 | 37 | 153 | 6 | GO:0045505 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.11e-06 | 28 | 153 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | TTF2 DYNC2H1 ATP8A2 CFTR ATP13A5 ATP9B CHD2 KIF24 NLRP3 BPTF ATP11B ABCA5 SMARCA2 DNAH5 DNAH6 DYNC1H1 DNAH11 | 5.02e-06 | 614 | 153 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.61e-05 | 70 | 153 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DYNC2H1 ATP8A2 CFTR ATP13A5 ATP9B CHD2 NLRP3 ATP11B ABCA5 DNAH5 DNAH6 DYNC1H1 DNAH11 | 3.63e-05 | 441 | 153 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | serotonin binding | 1.19e-04 | 13 | 153 | 3 | GO:0051378 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.98e-04 | 118 | 153 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | amine binding | 5.30e-04 | 21 | 153 | 3 | GO:0043176 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activator activity | 5.75e-04 | 5 | 153 | 2 | GO:0140608 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 6.10e-04 | 22 | 153 | 3 | GO:0004993 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DYNC2H1 ATP8A2 CFTR ATP13A5 ATP9B CHD2 NLRP3 ATP11B ABCA5 GNA12 GFM1 DNAH5 DNAH6 DYNC1H1 DNAH11 | 9.21e-04 | 775 | 153 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 1.19e-03 | 7 | 153 | 2 | GO:0090555 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 1.26e-03 | 28 | 153 | 3 | GO:0140326 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting serotonin receptor signaling pathway | 1.37e-05 | 7 | 153 | 3 | GO:0007198 | |
| GeneOntologyBiologicalProcess | gap junction-mediated intercellular transport | 1.37e-05 | 7 | 153 | 3 | GO:1990349 | |
| GeneOntologyBiologicalProcess | protein localization to cilium | 2.32e-05 | 77 | 153 | 6 | GO:0061512 | |
| GeneOntologyBiologicalProcess | positive regulation of motile cilium assembly | 5.47e-05 | 2 | 153 | 2 | GO:1905505 | |
| GeneOntologyBiologicalProcess | regulation of motile cilium assembly | 5.47e-05 | 2 | 153 | 2 | GO:1905503 | |
| GeneOntologyBiologicalProcess | regulation of exocytosis | 6.25e-05 | 233 | 153 | 9 | GO:0017157 | |
| GeneOntologyBiologicalProcess | intercellular transport | 6.32e-05 | 11 | 153 | 3 | GO:0010496 | |
| GeneOntologyCellularComponent | multivesicular body lumen | 1.34e-05 | 7 | 154 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | dynein complex | 4.81e-05 | 54 | 154 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | late endosome lumen | 6.20e-05 | 11 | 154 | 3 | GO:0031906 | |
| GeneOntologyCellularComponent | endosome lumen | 2.80e-04 | 43 | 154 | 4 | GO:0031904 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.90e-08 | 14 | 150 | 5 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.90e-08 | 14 | 150 | 5 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.90e-08 | 14 | 150 | 5 | IPR013602 | |
| Domain | DHC_N2 | 5.90e-08 | 14 | 150 | 5 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 5.90e-08 | 14 | 150 | 5 | IPR011704 | |
| Domain | MT | 5.90e-08 | 14 | 150 | 5 | PF12777 | |
| Domain | AAA_8 | 5.90e-08 | 14 | 150 | 5 | PF12780 | |
| Domain | AAA_5 | 5.90e-08 | 14 | 150 | 5 | PF07728 | |
| Domain | DHC_fam | 8.80e-08 | 15 | 150 | 5 | IPR026983 | |
| Domain | Dynein_heavy | 8.80e-08 | 15 | 150 | 5 | PF03028 | |
| Domain | Dynein_heavy_dom | 8.80e-08 | 15 | 150 | 5 | IPR004273 | |
| Domain | DHC_N1 | 2.73e-07 | 8 | 150 | 4 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 2.73e-07 | 8 | 150 | 4 | IPR013594 | |
| Domain | - | 7.93e-07 | 64 | 150 | 7 | 3.40.50.1000 | |
| Domain | HAD-like_dom | 3.35e-06 | 79 | 150 | 7 | IPR023214 | |
| Domain | Aspartic_peptidase_N | 1.74e-05 | 7 | 150 | 3 | IPR012848 | |
| Domain | A1_Propeptide | 1.74e-05 | 7 | 150 | 3 | PF07966 | |
| Domain | 5HT_rcpt | 4.12e-05 | 9 | 150 | 3 | IPR002231 | |
| Domain | Aspartic_peptidase_A1 | 5.85e-05 | 10 | 150 | 3 | IPR001461 | |
| Domain | PEPTIDASE_A1 | 5.85e-05 | 10 | 150 | 3 | IPR033121 | |
| Domain | Asp | 5.85e-05 | 10 | 150 | 3 | PF00026 | |
| Domain | PEPTIDASE_A1 | 5.85e-05 | 10 | 150 | 3 | PS51767 | |
| Domain | UBD | 6.41e-05 | 2 | 150 | 2 | IPR032752 | |
| Domain | UBD | 6.41e-05 | 2 | 150 | 2 | PF16455 | |
| Domain | - | 1.06e-04 | 12 | 150 | 3 | 2.40.70.10 | |
| Domain | ASP_PROTEASE | 1.06e-04 | 12 | 150 | 3 | PS00141 | |
| Domain | - | 1.21e-04 | 32 | 150 | 4 | 3.40.1110.10 | |
| Domain | - | 1.21e-04 | 32 | 150 | 4 | 2.70.150.10 | |
| Domain | Aspartic_peptidase_AS | 1.37e-04 | 13 | 150 | 3 | IPR001969 | |
| Domain | AAA | 1.64e-04 | 144 | 150 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.64e-04 | 144 | 150 | 7 | IPR003593 | |
| Domain | ATPase_P-typ_cyto_domN | 1.72e-04 | 35 | 150 | 4 | IPR023299 | |
| Domain | P_typ_ATPase_c | 1.73e-04 | 14 | 150 | 3 | IPR032630 | |
| Domain | P-type_ATPase_N | 1.73e-04 | 14 | 150 | 3 | IPR032631 | |
| Domain | P-type_ATPase_IV | 1.73e-04 | 14 | 150 | 3 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 1.73e-04 | 14 | 150 | 3 | PF16212 | |
| Domain | PhoLip_ATPase_N | 1.73e-04 | 14 | 150 | 3 | PF16209 | |
| Domain | Methyltransf_32 | 1.91e-04 | 3 | 150 | 2 | PF13679 | |
| Domain | ATPase_P-typ_P_site | 1.93e-04 | 36 | 150 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 1.93e-04 | 36 | 150 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.93e-04 | 36 | 150 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.15e-04 | 37 | 150 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.15e-04 | 37 | 150 | 4 | PF00122 | |
| Domain | Peptidase_aspartic_dom | 3.18e-04 | 17 | 150 | 3 | IPR021109 | |
| Domain | P-loop_NTPase | TTF2 DYNC2H1 CFTR IFI44 CHD2 KIF24 NLRP3 MAGI2 ABCA5 SMARCA2 GNA12 GFM1 DNAH5 DNAH6 DYNC1H1 DNAH11 TJP3 | 4.73e-04 | 848 | 150 | 17 | IPR027417 |
| Domain | Dullard_phosphatase | 6.31e-04 | 5 | 150 | 2 | IPR011948 | |
| Domain | PDZ | 9.77e-04 | 141 | 150 | 6 | PF00595 | |
| Domain | Bromodomain_CS | 1.15e-03 | 26 | 150 | 3 | IPR018359 | |
| Domain | PDZ | 1.26e-03 | 148 | 150 | 6 | SM00228 | |
| Domain | - | 1.34e-03 | 150 | 150 | 6 | 2.30.42.10 | |
| Domain | PDZ | 1.39e-03 | 151 | 150 | 6 | PS50106 | |
| Domain | PDZ | 1.44e-03 | 152 | 150 | 6 | IPR001478 | |
| Domain | CPDc | 1.74e-03 | 8 | 150 | 2 | SM00577 | |
| Domain | FCP1 | 1.74e-03 | 8 | 150 | 2 | PS50969 | |
| Domain | Methyltranfer_dom | 1.74e-03 | 8 | 150 | 2 | IPR025714 | |
| Domain | SNF2_N | 2.12e-03 | 32 | 150 | 3 | IPR000330 | |
| Domain | SNF2_N | 2.12e-03 | 32 | 150 | 3 | PF00176 | |
| Domain | NIF | 2.22e-03 | 9 | 150 | 2 | PF03031 | |
| Domain | FCP1_dom | 2.22e-03 | 9 | 150 | 2 | IPR004274 | |
| Domain | - | TTF2 DYNC2H1 CFTR IFI44 CHD2 ABCA5 SMARCA2 GNA12 GFM1 DNAH5 DNAH6 DYNC1H1 DNAH11 TJP3 | 2.78e-03 | 746 | 150 | 14 | 3.40.50.300 |
| Domain | BROMODOMAIN_1 | 3.23e-03 | 37 | 150 | 3 | PS00633 | |
| Domain | Bromodomain | 3.49e-03 | 38 | 150 | 3 | PF00439 | |
| Domain | VWFA | 4.30e-03 | 82 | 150 | 4 | PS50234 | |
| Domain | BROMODOMAIN_2 | 4.33e-03 | 41 | 150 | 3 | PS50014 | |
| Domain | Bromodomain | 4.63e-03 | 42 | 150 | 3 | IPR001487 | |
| Domain | BROMO | 4.63e-03 | 42 | 150 | 3 | SM00297 | |
| Domain | - | 4.63e-03 | 42 | 150 | 3 | 1.20.920.10 | |
| Domain | VWA | 4.69e-03 | 84 | 150 | 4 | SM00327 | |
| Domain | SAM_DOMAIN | 7.23e-03 | 95 | 150 | 4 | PS50105 | |
| Domain | SAM | 7.78e-03 | 97 | 150 | 4 | IPR001660 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 2.74e-05 | 45 | 112 | 5 | M47670 | |
| Pathway | WP_GASTRIC_ACID_PRODUCTION | 7.69e-05 | 11 | 112 | 3 | M39726 | |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 7.69e-05 | 11 | 112 | 3 | MM15008 | |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 1.02e-04 | 12 | 112 | 3 | M6034 | |
| Pubmed | 3.19e-09 | 14 | 155 | 5 | 9373155 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 7926498 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 9561228 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 21455714 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 19800305 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 24170207 | ||
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 8.68e-08 | 3 | 155 | 3 | 3014868 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 8.68e-08 | 3 | 155 | 3 | 2799289 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 19872561 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 8.68e-08 | 3 | 155 | 3 | 1968039 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 8053437 | ||
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 8.68e-08 | 3 | 155 | 3 | 2566575 | |
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 8.68e-08 | 3 | 155 | 3 | 2229438 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 25314140 | ||
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 8.68e-08 | 3 | 155 | 3 | 19890696 | |
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 8.68e-08 | 3 | 155 | 3 | 8244094 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 21407214 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 6774973 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 6300126 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 8.68e-08 | 3 | 155 | 3 | 22304859 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 24004680 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 8038355 | ||
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 8.68e-08 | 3 | 155 | 3 | 2227273 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 23034090 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 24125879 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 8751234 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 8.68e-08 | 3 | 155 | 3 | 3554488 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 23521833 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 3017318 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 8.68e-08 | 3 | 155 | 3 | 21989121 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 9855083 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 9797498 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 2478370 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 3815274 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 8.68e-08 | 3 | 155 | 3 | 10675278 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 3780036 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 2901984 | ||
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 8.68e-08 | 3 | 155 | 3 | 3839486 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 3467902 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 4586732 | ||
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 8.68e-08 | 3 | 155 | 3 | 2892778 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 24383519 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 8.68e-08 | 3 | 155 | 3 | 2831884 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 2032552 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 1812762 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 7923573 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 9061458 | ||
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 8.68e-08 | 3 | 155 | 3 | 12588289 | |
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 8.68e-08 | 3 | 155 | 3 | 23897256 | |
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 8.68e-08 | 3 | 155 | 3 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 8.68e-08 | 3 | 155 | 3 | 1956484 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 8540382 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 22992016 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 8.68e-08 | 3 | 155 | 3 | 20981206 | |
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 8.68e-08 | 3 | 155 | 3 | 8504820 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 8.68e-08 | 3 | 155 | 3 | 21970995 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 20428942 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 9525001 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 7886402 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 17379991 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 21547904 | ||
| Pubmed | Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. | 3.46e-07 | 4 | 155 | 3 | 23047493 | |
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 16824687 | ||
| Pubmed | Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. | 3.46e-07 | 4 | 155 | 3 | 11915945 | |
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 8322031 | ||
| Pubmed | Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression. | 3.46e-07 | 4 | 155 | 3 | 17136346 | |
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 12698190 | ||
| Pubmed | 8.63e-07 | 5 | 155 | 3 | 22066020 | ||
| Pubmed | Oligomerization of G-protein-coupled receptors shown by selective co-immunoprecipitation. | 4.78e-06 | 8 | 155 | 3 | 11854302 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYCBP2 CTC1 TXNRD2 C2CD2 HIRA CTDSP2 ZC3H11A LLGL2 SYNJ1 NBEAL2 PLA2G6 GNA12 RIC8A ELL DYNC1H1 HTT TJP3 | 9.64e-06 | 1105 | 155 | 17 | 35748872 |
| Pubmed | 1.02e-05 | 10 | 155 | 3 | 15919184 | ||
| Pubmed | 1.02e-05 | 10 | 155 | 3 | 19032968 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYCBP2 TTC21A TP53I11 SAMD12 ATP9B CHD2 ZHX2 C2CD2 BPTF ZC3H11A ATP11B GPR158 FAM120C GCC2 SMARCA2 PLA2G6 CTDSPL VPS13B HTT PDZD2 | 1.12e-05 | 1489 | 155 | 20 | 28611215 |
| Pubmed | 1.40e-05 | 11 | 155 | 3 | 18855532 | ||
| Pubmed | SORBS2 CLASP1 SYNE1 ZHX2 MAGI2 ZC3H11A GCC2 DYNC1H1 VPS13B PDZD2 | 1.57e-05 | 407 | 155 | 10 | 12693553 | |
| Pubmed | Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. | 1.59e-05 | 34 | 155 | 4 | 19060911 | |
| Pubmed | Maternal effects in infant and adult phenotypes of 5HT1A and 5HT1B receptor knockout mice. | 1.97e-05 | 2 | 155 | 2 | 12555283 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 17501853 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 30191727 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 1557407 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 1559993 | ||
| Pubmed | Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. | 1.97e-05 | 2 | 155 | 2 | 9826725 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 25170871 | ||
| Pubmed | Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor. | 1.97e-05 | 2 | 155 | 2 | 1652050 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 2714789 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 27493027 | ||
| Pubmed | Dual inhibition of complement C5 and CD14 attenuates inflammation in a cord blood model. | 1.97e-05 | 2 | 155 | 2 | 36725909 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 30816317 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 24098386 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 17417740 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 3197840 | ||
| Pubmed | Interaction of the inflammasome genes CARD8 and NLRP3 in abdominal aortic aneurysms. | 1.97e-05 | 2 | 155 | 2 | 21621776 | |
| Pubmed | Characterization of 5-HT(1A/1B)-/- mice: an animal model sensitive to anxiolytic treatments. | 1.97e-05 | 2 | 155 | 2 | 21333660 | |
| Pubmed | Genetic analysis of the cytoplasmic dynein subunit families. | 1.97e-05 | 2 | 155 | 2 | 16440056 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 12069904 | ||
| Pubmed | Genetic association of 5-HT1A and 5-HT1B gene polymorphisms with migraine in a Turkish population. | 1.97e-05 | 2 | 155 | 2 | 23375453 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 34587665 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 28185410 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 25268648 | ||
| Interaction | HTR1D interactions | 1.61e-06 | 4 | 150 | 3 | int:HTR1D | |
| Cytoband | 11q12-q13.1 | 1.68e-04 | 6 | 155 | 2 | 11q12-q13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q12 | 1.95e-04 | 84 | 155 | 4 | chr4q12 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 5.07e-05 | 13 | 104 | 3 | 170 | |
| GeneFamily | ATPase phospholipid transporting | 8.00e-05 | 15 | 104 | 3 | 1210 | |
| GeneFamily | Dyneins, axonemal | 1.19e-04 | 17 | 104 | 3 | 536 | |
| GeneFamily | PDZ domain containing | 2.46e-04 | 152 | 104 | 6 | 1220 | |
| GeneFamily | CTD family phosphatases | 8.97e-04 | 8 | 104 | 2 | 1041 | |
| GeneFamily | Sterile alpha motif domain containing | 1.66e-03 | 88 | 104 | 4 | 760 | |
| GeneFamily | Dyneins, cytoplasmic | 2.45e-03 | 13 | 104 | 2 | 538 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.28e-03 | 15 | 104 | 2 | 529 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | INTS6L CAB39 IL16 PHF20 MYCBP2 SYNE1 POLR2B IFI44 CHD2 IL18R1 CARD8 ITK BPTF CD3D ZC3H11A ATP11B NBEAL2 CRTAM SMARCA2 ELL DYNC1H1 VPS13B MAST3 USP47 | 7.56e-06 | 1492 | 155 | 24 | M40023 |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.13e-07 | 187 | 155 | 8 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 3.26e-07 | 188 | 155 | 8 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.47e-07 | 196 | 155 | 8 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.65e-07 | 197 | 155 | 8 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.65e-07 | 197 | 155 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.65e-07 | 197 | 155 | 8 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.65e-07 | 197 | 155 | 8 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.65e-07 | 197 | 155 | 8 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.21e-07 | 200 | 155 | 8 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 2.01e-06 | 167 | 155 | 7 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-06 | 169 | 155 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.26e-06 | 170 | 155 | 7 | d682178d11d67eb5a02d0c6b3967645e37bcc62a | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 171 | 155 | 7 | 246fc7edcefc47437d1df6029f295aca3b34b2b2 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 171 | 155 | 7 | 1fb4e11f92b48dc2d6e553c22e2571bbd8c223c6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.18e-06 | 179 | 155 | 7 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.30e-06 | 180 | 155 | 7 | a999a6d219a8e58a8b63802ddf8c95ffaab9cfa0 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.95e-06 | 185 | 155 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.95e-06 | 185 | 155 | 7 | e1fd66f4295056807aa29c0e4ce6b1a79cc8dfcf | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.39e-06 | 188 | 155 | 7 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Ciliated-cil-3|World / Class top | 5.04e-06 | 192 | 155 | 7 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.40e-06 | 194 | 155 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 5.58e-06 | 195 | 155 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 5.58e-06 | 195 | 155 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-06 | 195 | 155 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.58e-06 | 195 | 155 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.58e-06 | 195 | 155 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.58e-06 | 195 | 155 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-06 | 195 | 155 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.77e-06 | 196 | 155 | 7 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.77e-06 | 196 | 155 | 7 | 609959609ab1870c562cefca0fd49e0d701d1e5b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.97e-06 | 197 | 155 | 7 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.97e-06 | 197 | 155 | 7 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.97e-06 | 197 | 155 | 7 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.97e-06 | 197 | 155 | 7 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.37e-06 | 199 | 155 | 7 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.37e-06 | 199 | 155 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.37e-06 | 199 | 155 | 7 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | 6.37e-06 | 199 | 155 | 7 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.37e-06 | 199 | 155 | 7 | 74087b4b5e567310fc4ac58fb267ff651a180680 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.37e-06 | 199 | 155 | 7 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | Mild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 6.37e-06 | 199 | 155 | 7 | ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18 | |
| ToppCell | Mild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 6.37e-06 | 199 | 155 | 7 | 91308b255783ad4029e5575028c18d7550832c51 | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 6.37e-06 | 199 | 155 | 7 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 6.59e-06 | 200 | 155 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.73e-06 | 140 | 155 | 6 | 8abbd5dc799943b49cd0045d0da405c3f3d0db6b | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_ciliated|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.73e-06 | 140 | 155 | 6 | e4689232c473d239b07a7fbcaaa3414fbd9badea | |
| ToppCell | normal_Lung-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.44e-05 | 150 | 155 | 6 | b81f8dfc7755252c457e38bb32b103af3b6f1c01 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 155 | 155 | 6 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-05 | 155 | 155 | 6 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.87e-05 | 157 | 155 | 6 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 158 | 155 | 6 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 158 | 155 | 6 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 158 | 155 | 6 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.23e-05 | 162 | 155 | 6 | 2f19539c455d1e5d514725845234c7547020e6ad | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 163 | 155 | 6 | bc37c5d9f48b16096d5313657563f3ec84028c8c | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 165 | 155 | 6 | eeb58d4db64ad37dc6b441eab22b05c24862e1a9 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-05 | 165 | 155 | 6 | 1a114eacaab598f755a173a3fed842ba91f689dd | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Club_cells-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-05 | 165 | 155 | 6 | 9cfd3c1d2c6d714fde83b90465f1f9741b0e50ce | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-05 | 169 | 155 | 6 | f077e39e41fffe7672541f5b72b80faaf56c597c | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.92e-05 | 170 | 155 | 6 | 35e3945d8a540a3e2cec1b559316265aaad023d1 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.92e-05 | 170 | 155 | 6 | 0ea625abaa25bab93b70b7000e8f90d5c0f9a0fb | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.92e-05 | 170 | 155 | 6 | 0b5ddc7d452db0a389927a367914f7d257703f7e | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Pvalb_(Layer_5a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.99e-05 | 51 | 155 | 4 | 28d6b12c44ad308560931d275e0dd0243a555bf3 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 171 | 155 | 6 | 5447b78148f7bccb727e2fc108589b2af02a5d31 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 172 | 155 | 6 | a7eee0a30d2fe20c865a07b9004c6a821a72c0c4 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-05 | 172 | 155 | 6 | c05af6e559f6af0fb15cefa03ffa1413e98a1a4a | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 172 | 155 | 6 | 0a9fe2cd28203970295a1288078c66eadac1c9ed | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Basophil|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-05 | 172 | 155 | 6 | 953b05f776348cff784e79c93df65841939d880f | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.22e-05 | 173 | 155 | 6 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.33e-05 | 174 | 155 | 6 | 7c8cc5c2872fc7bcca7ebddaf5a6f20e617a2674 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 177 | 155 | 6 | 52402ff6299210c46fd9dee3cef203c0eda7a98a | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 178 | 155 | 6 | 41745a589567ca5ea6d06331f4c8da03595b5f5c | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 178 | 155 | 6 | eb940dd64c973f68bcaad6069d3bd56383329db5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.78e-05 | 178 | 155 | 6 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-ILC_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.90e-05 | 179 | 155 | 6 | d18a520568cf4b031972d3dd7d4d4bd073ac1fea | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 180 | 155 | 6 | 5c649e2b3f5a53c0040b69df6e289fb3427ef2db | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.02e-05 | 180 | 155 | 6 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.02e-05 | 180 | 155 | 6 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.15e-05 | 181 | 155 | 6 | bad77767e64cc093a827a6b0f3f401f3f108e457 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.28e-05 | 182 | 155 | 6 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Lymphocytic-lymphocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 183 | 155 | 6 | a305667cfdae50e64e1890f10f71b407ae617b80 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.41e-05 | 183 | 155 | 6 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 184 | 155 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.55e-05 | 184 | 155 | 6 | 7ecdf2645e9378cf2f5ce4557f2cf100e6f184ba | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 184 | 155 | 6 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 184 | 155 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 184 | 155 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 184 | 155 | 6 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 184 | 155 | 6 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.69e-05 | 185 | 155 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-CD56_bright_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.69e-05 | 185 | 155 | 6 | 593eceb3dfcc662c892a840ba29ab687c6886c01 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.83e-05 | 186 | 155 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 187 | 155 | 6 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.97e-05 | 187 | 155 | 6 | 50d5730e2cd4951d3ad0641fc81ae9f6ddabafe7 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 187 | 155 | 6 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | multiciliated|World / shred by cell class for bronchial biopsy | 5.12e-05 | 188 | 155 | 6 | 6833c1f0f265ef5448fa65033550ed7efc2f8d7b | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 188 | 155 | 6 | 90dc0e15798d0b984518ad58c7e416e30aff687a | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 5.12e-05 | 188 | 155 | 6 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 5.12e-05 | 188 | 155 | 6 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 188 | 155 | 6 | f63dfd076ced81013918363282ae25cbbd8948ae | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.14e-05 | 49 | 93 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | C acid | 3.63e-08 | 29 | 154 | 6 | CID000008563 | |
| Drug | carmoxirole | 1.38e-07 | 8 | 154 | 4 | CID000057364 | |
| Drug | spirilene | 3.03e-07 | 3 | 154 | 3 | CID006436870 | |
| Drug | MK-212 | 9.50e-07 | 27 | 154 | 5 | CID000107992 | |
| Drug | Zolmitriptan | 1.21e-06 | 4 | 154 | 3 | DB00315 | |
| Drug | Is 159 | 1.21e-06 | 4 | 154 | 3 | CID000196859 | |
| Drug | PD 158771 | 1.21e-06 | 4 | 154 | 3 | CID003075615 | |
| Drug | Naratriptan | 1.21e-06 | 4 | 154 | 3 | DB00952 | |
| Drug | LY206130 | 1.21e-06 | 4 | 154 | 3 | CID000124433 | |
| Drug | Sumatriptan | 1.21e-06 | 4 | 154 | 3 | DB00669 | |
| Drug | PD 118717 | 1.21e-06 | 4 | 154 | 3 | CID000128518 | |
| Drug | SKF 99101H | 1.21e-06 | 4 | 154 | 3 | CID000182576 | |
| Drug | anpirtoline | 1.37e-06 | 13 | 154 | 4 | CID000065854 | |
| Drug | p790 | 1.37e-06 | 13 | 154 | 4 | CID000007625 | |
| Drug | flumazenil | 1.72e-06 | 54 | 154 | 6 | CID000003373 | |
| Drug | YM-09151-2 | 2.30e-06 | 32 | 154 | 5 | CID000004452 | |
| Drug | Trelibet | 3.00e-06 | 5 | 154 | 3 | CID000065975 | |
| Drug | eptapirone | 3.00e-06 | 5 | 154 | 3 | CID000208928 | |
| Drug | CP-135,807 | 3.00e-06 | 5 | 154 | 3 | CID005487088 | |
| Drug | 4-amino-5-chloro-2-methoxybenzamide | 3.00e-06 | 5 | 154 | 3 | CID009834239 | |
| Drug | I 370 | 3.00e-06 | 5 | 154 | 3 | CID000089576 | |
| Drug | centbutindole | 3.00e-06 | 5 | 154 | 3 | CID000068663 | |
| Drug | CP-132,484 | 3.00e-06 | 5 | 154 | 3 | CID000132564 | |
| Drug | AC1LCKBJ | 3.00e-06 | 5 | 154 | 3 | CID000601768 | |
| Drug | N-methylmorpholine | 4.36e-06 | 97 | 154 | 7 | CID000007972 | |
| Drug | triethylenephosphoramide | 5.16e-06 | 65 | 154 | 6 | CID000011016 | |
| Drug | pAPP | 5.72e-06 | 18 | 154 | 4 | CID000121930 | |
| Drug | pyrrolo(1,2-a)quinoxaline | 5.98e-06 | 6 | 154 | 3 | CID000067476 | |
| Drug | (125i)gti | 5.98e-06 | 6 | 154 | 3 | CID000131670 | |
| Drug | R 28935 | 5.98e-06 | 6 | 154 | 3 | CID000093307 | |
| Drug | 5-aminotryptamine | 5.98e-06 | 6 | 154 | 3 | CID003083677 | |
| Drug | NDO 008 | 5.98e-06 | 6 | 154 | 3 | CID000131001 | |
| Drug | adafenoxate | 1.04e-05 | 7 | 154 | 3 | CID000064517 | |
| Drug | Eletriptan | 1.04e-05 | 7 | 154 | 3 | DB00216 | |
| Drug | BRL 34778 | 1.04e-05 | 7 | 154 | 3 | CID000135770 | |
| Drug | NAD-299 | 1.04e-05 | 7 | 154 | 3 | CID000451066 | |
| Drug | 2,2'-pyridylisatogen | 1.04e-05 | 7 | 154 | 3 | CID000124333 | |
| Drug | LY334370 | 1.04e-05 | 7 | 154 | 3 | CID005311258 | |
| Drug | [18f]fbway 1,3 N | 1.04e-05 | 7 | 154 | 3 | CID005352127 | |
| Drug | benzimidazolone | 1.10e-05 | 21 | 154 | 4 | CID000088638 | |
| Drug | zacopride | 1.34e-05 | 22 | 154 | 4 | CID000108182 | |
| Drug | mCPBG | 1.34e-05 | 22 | 154 | 4 | CID000001354 | |
| Drug | tertatolol | 1.34e-05 | 22 | 154 | 4 | CID000036920 | |
| Drug | AC1NSK2T | 1.62e-05 | 47 | 154 | 5 | CID005311143 | |
| Drug | BP-554 | 1.66e-05 | 8 | 154 | 3 | CID000134117 | |
| Drug | AC1L5AAF | 1.66e-05 | 8 | 154 | 3 | CID000173615 | |
| Drug | SB 216641 | 1.66e-05 | 8 | 154 | 3 | CID003292447 | |
| Drug | cinitapride | 1.66e-05 | 8 | 154 | 3 | CID000068867 | |
| Drug | S 14489 | 1.66e-05 | 8 | 154 | 3 | CID000182595 | |
| Drug | 5-OHIP | 1.66e-05 | 8 | 154 | 3 | CID000182581 | |
| Drug | 5-fluoro-alpha-methyltryptamine | 1.66e-05 | 8 | 154 | 3 | CID000012834 | |
| Drug | 3-PPP | 1.92e-05 | 24 | 154 | 4 | CID000055445 | |
| Drug | melantonin | 2.47e-05 | 9 | 154 | 3 | CID000077899 | |
| Drug | CQ 32-084 | 2.47e-05 | 9 | 154 | 3 | CID000068847 | |
| Drug | AHPP | 2.47e-05 | 9 | 154 | 3 | CID000128891 | |
| Drug | S 15931 | 2.47e-05 | 9 | 154 | 3 | CID000182596 | |
| Drug | U91356A | 2.47e-05 | 9 | 154 | 3 | CID000132955 | |
| Drug | AC1L1IZE | 3.13e-05 | 131 | 154 | 7 | CID000004799 | |
| Drug | diphenyl | 3.28e-05 | 132 | 154 | 7 | CID000007095 | |
| Drug | 5-OH-DPAT | 3.52e-05 | 10 | 154 | 3 | CID000172267 | |
| Drug | CM 29-712 | 3.52e-05 | 10 | 154 | 3 | CID000159842 | |
| Drug | Yohimbine | 3.52e-05 | 10 | 154 | 3 | DB01392 | |
| Drug | BIMT 17 BS | 3.52e-05 | 10 | 154 | 3 | CID006918248 | |
| Drug | ziprasidone | 3.52e-05 | 10 | 154 | 3 | ctd:C092292 | |
| Drug | alpha-Bcp | 3.52e-05 | 10 | 154 | 3 | CID000137309 | |
| Drug | 5-HTQ | 3.52e-05 | 10 | 154 | 3 | CID000656705 | |
| Drug | 2-(di-n-propylamino)tetralin | 3.52e-05 | 10 | 154 | 3 | CID000090285 | |
| Drug | seganserin | 3.52e-05 | 10 | 154 | 3 | CID000071767 | |
| Drug | S 14671 | 3.52e-05 | 10 | 154 | 3 | CID000131907 | |
| Drug | S 14297 | 3.52e-05 | 10 | 154 | 3 | CID000115007 | |
| Drug | LY344864 | 3.52e-05 | 10 | 154 | 3 | CID005311097 | |
| Drug | AC1L1CCX | 3.52e-05 | 10 | 154 | 3 | CID000001840 | |
| Drug | U-86170F | 3.52e-05 | 10 | 154 | 3 | CID000131559 | |
| Drug | SDZ 208-912 | 3.52e-05 | 10 | 154 | 3 | CID000058145 | |
| Drug | 4a,5-dihydromevinolin | 4.55e-05 | 2 | 154 | 2 | CID000196514 | |
| Drug | 6,7-DHT | 4.55e-05 | 2 | 154 | 2 | CID000039719 | |
| Drug | 8-methoxy-2'-chloro-PAT | 4.55e-05 | 2 | 154 | 2 | CID000125955 | |
| Drug | 5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H indole | 4.55e-05 | 2 | 154 | 2 | ctd:C025145 | |
| Drug | JMC-181 | 4.55e-05 | 2 | 154 | 2 | CID000134385 | |
| Drug | 8-Azabicyclo[3.2.1]oct-2-ene | 4.55e-05 | 2 | 154 | 2 | CID000138546 | |
| Drug | N,N-dipropyl-6,7-ADTN | 4.55e-05 | 2 | 154 | 2 | CID000125246 | |
| Drug | Frovatriptan | 4.55e-05 | 2 | 154 | 2 | DB00998 | |
| Drug | Almotriptan | 4.55e-05 | 2 | 154 | 2 | DB00918 | |
| Drug | 3-(4-piperidyl)-1H-indole | 4.55e-05 | 2 | 154 | 2 | CID000702235 | |
| Drug | tertatolol | 4.55e-05 | 2 | 154 | 2 | ctd:C005632 | |
| Drug | PD 128483 | 4.55e-05 | 2 | 154 | 2 | CID000130792 | |
| Drug | naratriptan | 4.55e-05 | 2 | 154 | 2 | ctd:C106783 | |
| Drug | 2,5diPhOxadiazo | 4.55e-05 | 2 | 154 | 2 | CID000456811 | |
| Drug | 3-phenethyl-PP | 4.55e-05 | 2 | 154 | 2 | CID000167838 | |
| Drug | GR 46611 | 4.55e-05 | 2 | 154 | 2 | ctd:C119994 | |
| Drug | cyanoacetic acid | 4.55e-05 | 2 | 154 | 2 | CID000009740 | |
| Drug | thioflavone | 4.55e-05 | 2 | 154 | 2 | CID000069914 | |
| Drug | RU 23686 | 4.55e-05 | 2 | 154 | 2 | CID000043223 | |
| Drug | DS121 | 4.55e-05 | 2 | 154 | 2 | CID000005119 | |
| Drug | p-azido-PAPP | 4.55e-05 | 2 | 154 | 2 | CID000128737 | |
| Drug | 8-methoxy-3'-NAP-amino-PAT | 4.55e-05 | 2 | 154 | 2 | CID003035902 | |
| Drug | Anabolic Agents | 4.55e-05 | 2 | 154 | 2 | ctd:D045930 | |
| Drug | BRL 15572 | 4.55e-05 | 2 | 154 | 2 | ctd:C108532 | |
| Drug | N-(3-(2-dimethylamino)ethoxy-4-methoxyphenyl)-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-(1,1'-biphenyl)-4-carboxamide | 4.55e-05 | 2 | 154 | 2 | ctd:C108531 | |
| Drug | PD 120697 | 4.55e-05 | 2 | 154 | 2 | CID000194776 | |
| Disease | generalized anxiety disorder (implicated_via_orthology) | 7.08e-06 | 8 | 150 | 3 | DOID:14320 (implicated_via_orthology) | |
| Disease | Diarrhea | 6.87e-05 | 16 | 150 | 3 | HP_0002014 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.04e-04 | 91 | 150 | 5 | EFO_0004611, EFO_0005271 | |
| Disease | Kartagener syndrome (is_implicated_in) | 1.53e-04 | 4 | 150 | 2 | DOID:0050144 (is_implicated_in) | |
| Disease | asthma (is_implicated_in) | 1.57e-04 | 157 | 150 | 6 | DOID:2841 (is_implicated_in) | |
| Disease | facial morphology | 1.79e-04 | 55 | 150 | 4 | EFO_0004743 | |
| Disease | Bronchiectasis | 1.85e-04 | 22 | 150 | 3 | C0006267 | |
| Disease | Ciliopathies | 2.53e-04 | 110 | 150 | 5 | C4277690 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 3.62e-04 | 66 | 150 | 4 | EFO_0003940, EFO_0004611 | |
| Disease | Cataract, Central Saccular, With Sutural Opacities | 3.80e-04 | 6 | 150 | 2 | C1854021 | |
| Disease | corpus callosum central volume measurement | 3.84e-04 | 28 | 150 | 3 | EFO_0010296 | |
| Disease | Parkinson's disease (is_implicated_in) | 6.20e-04 | 76 | 150 | 4 | DOID:14330 (is_implicated_in) | |
| Disease | Primary ciliary dyskinesia | 8.13e-04 | 36 | 150 | 3 | cv:C0008780 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 9.03e-04 | 9 | 150 | 2 | C0085548 | |
| Disease | Gout | 9.03e-04 | 9 | 150 | 2 | C0018099 | |
| Disease | clinical treatment | 1.19e-03 | 41 | 150 | 3 | EFO_0007056 | |
| Disease | Myoclonic Astatic Epilepsy | 1.37e-03 | 11 | 150 | 2 | C0393702 | |
| Disease | bronchopulmonary dysplasia | 1.56e-03 | 45 | 150 | 3 | MONDO_0019091 | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 1.67e-03 | 46 | 150 | 3 | EFO_0005325, HP_0012735 | |
| Disease | Primary Ciliary Dyskinesia | 1.77e-03 | 47 | 150 | 3 | C4551720 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 1.79e-03 | 101 | 150 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | matrix metalloproteinase measurement | 1.93e-03 | 13 | 150 | 2 | EFO_0004744 | |
| Disease | Hyperlipoproteinemia Type IIb | 1.93e-03 | 13 | 150 | 2 | C1704417 | |
| Disease | Seizures, Focal | 1.99e-03 | 104 | 150 | 4 | C0751495 | |
| Disease | Pain, Migratory | 2.00e-03 | 49 | 150 | 3 | C0751407 | |
| Disease | Suffering, Physical | 2.00e-03 | 49 | 150 | 3 | C0751408 | |
| Disease | Pain, Crushing | 2.00e-03 | 49 | 150 | 3 | C0458259 | |
| Disease | Pain, Splitting | 2.00e-03 | 49 | 150 | 3 | C0458257 | |
| Disease | Pain | 2.00e-03 | 49 | 150 | 3 | C0030193 | |
| Disease | Radiating pain | 2.00e-03 | 49 | 150 | 3 | C0234254 | |
| Disease | Pain, Burning | 2.00e-03 | 49 | 150 | 3 | C0234230 | |
| Disease | Ache | 2.00e-03 | 49 | 150 | 3 | C0234238 | |
| Disease | carotid artery intima media thickness | 2.20e-03 | 450 | 150 | 8 | EFO_0007117 | |
| Disease | orotic acid measurement | 2.24e-03 | 14 | 150 | 2 | EFO_0010516 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 2.24e-03 | 14 | 150 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 2.24e-03 | 14 | 150 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | generalised epilepsy | 2.37e-03 | 52 | 150 | 3 | EFO_0005917 | |
| Disease | Hypotension | 2.50e-03 | 53 | 150 | 3 | C0020649 | |
| Disease | Alcoholic Intoxication, Chronic | 2.55e-03 | 268 | 150 | 6 | C0001973 | |
| Disease | Ischemic stroke, fibrinogen measurement | 2.78e-03 | 55 | 150 | 3 | EFO_0004623, HP_0002140 | |
| Disease | antihyperlipidemic drug use measurement | 2.87e-03 | 115 | 150 | 4 | EFO_0803367 | |
| Disease | Congenital total cataract | 2.94e-03 | 16 | 150 | 2 | C0266539 | |
| Disease | Hyperlipoproteinemia Type IIa | 2.94e-03 | 16 | 150 | 2 | C0745103 | |
| Disease | proliferative diabetic retinopathy (is_marker_for) | 2.94e-03 | 16 | 150 | 2 | DOID:13207 (is_marker_for) | |
| Disease | thyroid volume | 2.94e-03 | 16 | 150 | 2 | EFO_0004865 | |
| Disease | Cocaine-Related Disorders | 3.05e-03 | 117 | 150 | 4 | C0236736 | |
| Disease | coronary artery disease | SORBS2 DYNC2H1 CFTR CHD2 APOB HMGCR HIRA SGCZ CD3D ZC3H11A STXBP2 C5 LNX1 ELL | 3.17e-03 | 1194 | 150 | 14 | EFO_0001645 |
| Disease | cervical artery dissection | 3.32e-03 | 17 | 150 | 2 | EFO_1000059 | |
| Disease | metabolic syndrome | 3.64e-03 | 200 | 150 | 5 | EFO_0000195 | |
| Disease | Nuclear non-senile cataract | 3.72e-03 | 18 | 150 | 2 | C1112705 | |
| Disease | Nuclear cataract | 3.72e-03 | 18 | 150 | 2 | C0392557 | |
| Disease | level of Phosphatidylcholine (20:4_0:0) in blood serum | 3.72e-03 | 18 | 150 | 2 | OBA_2045110 | |
| Disease | Hypercholesterolemia, Familial | 3.72e-03 | 18 | 150 | 2 | C0020445 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.83e-03 | 291 | 150 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | cystic fibrosis (is_marker_for) | 3.91e-03 | 62 | 150 | 3 | DOID:1485 (is_marker_for) | |
| Disease | Cocaine Abuse | 4.09e-03 | 127 | 150 | 4 | C0009171 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 4.15e-03 | 19 | 150 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 4.15e-03 | 19 | 150 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | Astigmatism | 4.32e-03 | 129 | 150 | 4 | HP_0000483 | |
| Disease | acute lymphoblastic leukemia | 4.66e-03 | 66 | 150 | 3 | EFO_0000220 | |
| Disease | primary biliary cirrhosis | 4.81e-03 | 133 | 150 | 4 | EFO_1001486 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 4.94e-03 | 215 | 150 | 5 | EFO_0008317, EFO_0008591 | |
| Disease | serum alanine aminotransferase measurement | 4.98e-03 | 869 | 150 | 11 | EFO_0004735 | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 5.06e-03 | 21 | 150 | 2 | OBA_2045104 | |
| Disease | level of Phosphatidylcholine (16:0_20:4) in blood serum | 5.06e-03 | 21 | 150 | 2 | OBA_2045076 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LRKEIRSLLISTKDG | 11 | Q8NAT2 | |
| KRESKSVRSVLLLLL | 856 | Q8WWZ7 | |
| IISKLDKLSVLRLSV | 61 | A9YTQ3 | |
| DRSALLKSKLRALLT | 106 | P01160 | |
| AARERKATKTLGIIL | 306 | P28222 | |
| IRSIKIRDSKFGLAL | 206 | Q8N3I7 | |
| LSIERRKKRSTGVLL | 281 | P12645 | |
| TGEIVALKKVALRRL | 26 | Q8IZL9 | |
| LLSDITRLDLGKRIL | 51 | P04234 | |
| TKLVLKELSEARIRT | 701 | Q4VNC0 | |
| KRKDVALLVTSGLAL | 286 | P46092 | |
| RKAELLLRLQKDGLT | 221 | P55199 | |
| VITLSLAGRRLDKKD | 156 | Q96FN4 | |
| KLSSRVLDKISIGQL | 166 | P13569 | |
| GVKFRSDLSRLLTKL | 326 | P32302 | |
| LAGSLVRLSALVKSK | 226 | Q2NKJ3 | |
| KLVKDSIAEGRISLR | 86 | Q6UX41 | |
| DDKATIIRVGKSLLI | 781 | Q5T601 | |
| GAARLTALRIKKTLS | 481 | P36896 | |
| KSKTLEFDRRLGTII | 541 | Q96DT5 | |
| KRQSLKLLGELLLDR | 226 | Q9Y376 | |
| KSIRLLSEIEKLVGT | 591 | Q4L235 | |
| TKSSKLDGLLERRIK | 1181 | Q12830 | |
| RRKIVTLDSLEDTKL | 16 | P52569 | |
| ELETKSRVLGKAVLR | 1106 | Q9NTI2 | |
| KLRSVISEHIKRTGL | 246 | Q6IQ32 | |
| RLKSISERLSVLKGA | 226 | P30301 | |
| TDLVSRLKTRKILGV | 16 | O14683 | |
| KLLKEITGETALRLT | 471 | Q5JSJ4 | |
| RKTFRLSAKSGELLL | 291 | Q9Y5E7 | |
| KSLRRTLSERGLLKD | 26 | P0DJD9 | |
| KTKVSLRGETLTLQL | 11 | E5RJ46 | |
| LSLRGKLVKEVTSRA | 506 | Q8IYY4 | |
| ARDGKLRLLTKLLAS | 11 | Q96JP0 | |
| KRDDVLIGLKSTALR | 256 | Q96H96 | |
| ISRLVRSLSLLLKGV | 596 | Q6ZVH7 | |
| SLIEKSRRLIIVLSK | 431 | Q13478 | |
| ALTRKLEAVSKRLAI | 476 | P21941 | |
| IVKLIKDAGLSVTLR | 991 | Q86UL8 | |
| LKLKLTALEGSRVRR | 831 | Q6P1M3 | |
| TLLRKERGVKLLDIS | 246 | Q9H3P2 | |
| FRKAKSIRASGLILL | 441 | Q5T848 | |
| GVSIRRQLLSKKLSE | 491 | P04035 | |
| RLLLIATGKRTLLID | 761 | Q9NQW6 | |
| AREGLRTLVVAKKAL | 681 | O43861 | |
| VRRSLKKLGLDESKL | 511 | Q8N6Q8 | |
| SSLERTLLSLKVLRK | 206 | Q9UI26 | |
| VLRADASIRLLKATK | 71 | Q9NRM6 | |
| ASRLKSILKLDGDVL | 26 | Q9BRT6 | |
| LDSALLERKRLLSRK | 401 | P41279 | |
| KATLLRKLSRTGLVG | 421 | Q8IWD5 | |
| DLDSIFRRIRTLKGK | 76 | Q9BQD3 | |
| LKTILSIASLAERLK | 221 | Q8NH64 | |
| GKSGKVRLRDEILSL | 131 | O15018 | |
| VSKLKILRLGSCRLT | 141 | Q6UY01 | |
| KKGLLTLTVRTRLTA | 291 | Q14005 | |
| ELLLEVILKGSKERS | 401 | Q5T7B8 | |
| ARLLKELKGRITLTI | 706 | Q8TBB1 | |
| LTLRDTVLLRKESRK | 656 | Q9NY33 | |
| IRTRLEKEGIVFKSL | 1636 | Q9UKK3 | |
| LLREASGILKVRALK | 276 | Q8WXE0 | |
| KSLRRTLSERGLLKD | 26 | P0DJD8 | |
| EKRLSKVDTLRLAIG | 196 | Q7RTS3 | |
| IKAVLGLTKRRLVSS | 966 | Q86YC2 | |
| LELGGLKISTLRKLV | 76 | B2RXH4 | |
| GIVLRRSDTNLTKLK | 146 | Q8NCM8 | |
| LEGTTRLTRKRGLKL | 3381 | P04114 | |
| RLTRKRGLKLATALS | 3386 | P04114 | |
| SRLKELTLEDLKITG | 116 | P08571 | |
| LTKARLVRAGKLTAA | 2956 | Q9C0G6 | |
| LKALDTRFGRKLSII | 2536 | P42858 | |
| KGVIELRKSLLSALR | 161 | Q8TCB0 | |
| GITLTRILNKKLLSR | 666 | Q9Y426 | |
| DKSLEERGRILISLK | 261 | Q14184 | |
| TDKTGVIKAARLLLS | 136 | Q9UBT7 | |
| SKRLEIEKSLLVRAS | 181 | Q96BQ5 | |
| LARKKSGILLLTLVS | 281 | O95727 | |
| GKLILLDKLLTRLRE | 791 | O14647 | |
| DLLRKRERELTALKG | 751 | Q0VF96 | |
| KDLSRLGRELSKVII | 206 | O15194 | |
| KDLSRLGRDLRKTLI | 201 | O14595 | |
| KGTKKFRLEGTLLRT | 136 | P48165 | |
| RSIVSALKREALVKG | 1206 | P01031 | |
| KLIKAGRERVSLVEL | 861 | Q9NX05 | |
| RRAELILLKDSLAKS | 921 | Q8IWJ2 | |
| SKLIRLQGSRKLLVD | 31 | Q9Y2G2 | |
| CLSKRTRRSIEKLLE | 106 | Q9UKJ5 | |
| ILKGSRVLVDARDKL | 101 | Q03113 | |
| ALARERKTVKTLGII | 336 | P08908 | |
| ISAARERKATKILGI | 291 | P28221 | |
| RTEEEIKKILGLLSL | 71 | A0A1B0GTR0 | |
| RSKIDRLETTLAGIK | 151 | Q8IX19 | |
| ELLLKSGNKISLRTT | 1021 | O60307 | |
| RDLSSQLLKVLGTRK | 386 | Q14204 | |
| RADSVLKGLKLVLLV | 326 | Q17R55 | |
| KIEKILSTLVKGTRR | 136 | Q9NX74 | |
| STVVGLRKRELLKEL | 976 | P54198 | |
| LTALVDIVRSLKKSG | 421 | Q9Y5Q0 | |
| ISDLKLAIRRATLKR | 276 | Q96RP9 | |
| SDLTIRGRLLSLVEK | 2021 | Q92736 | |
| LKDGVIKLRSVTSRE | 471 | P12081 | |
| LSLIRAKKRSDELGL | 476 | Q8NEC7 | |
| ATLIGLSIKVKLLRS | 96 | Q9Y3D0 | |
| TDSIIALGKRLKIET | 4056 | Q8TE73 | |
| IAILKLLDKARISTR | 561 | Q6UXH9 | |
| KSLRRTLSERGLLKD | 26 | P0DJD7 | |
| ITLELRRRKISKGCE | 281 | Q9BVI0 | |
| GKKRTLKGSIELSRI | 46 | Q08881 | |
| LRLKSVRLLSGSREK | 251 | P41145 | |
| TLRNKDVKGALRTLI | 291 | Q5TZ20 | |
| ERGDILLSSLIRKKL | 326 | Q96P20 | |
| TKKREGLIRTRLLGA | 206 | Q49A17 | |
| LKVAGSLKELIDRSL | 1291 | Q8NET4 | |
| DLRTKATVELKALRL | 371 | P51531 | |
| LLRLKKVDTATLRSE | 6866 | Q8NF91 | |
| GKELLNRTITIALKS | 956 | O43426 | |
| ISLLKKSGIEVRLIS | 311 | Q8NFW8 | |
| KSRILLGKTGVIREE | 556 | Q8IZX4 | |
| RVLALLTKLVAELKG | 106 | Q6ZNJ1 | |
| SKAKAARLVRSLLDL | 81 | O00231 | |
| RSLQGKAELRRLLTK | 221 | Q02127 | |
| LELAIKTRIISDGLK | 431 | P30876 | |
| LRLTDKIVRKAGNLT | 41 | Q8WVM0 | |
| ITGRALLRLTDKKLE | 106 | Q8N8I0 | |
| ECIGKTRTLLRKILS | 1496 | O75592 | |
| LRVTKKGIRLEGISE | 71 | Q96LD1 | |
| SKIGRLVTRKAILTL | 391 | O60733 | |
| SRGTKLRKLILSDEL | 231 | Q9UBF8 | |
| LKGVRLLTDTLELTL | 186 | Q9NPQ8 | |
| ELSLRKGDRVILLKR | 956 | O94875 | |
| TLKLLGRLSLLSEEI | 626 | Q9UNK9 | |
| RKGALLELLKITRED | 1321 | Q7Z460 | |
| SLLLRGARLKNTKEI | 241 | Q9Y2G3 | |
| SLGLFLKIELRKRSD | 36 | P23942 | |
| SRSRKLILAQKLSEL | 801 | O75717 | |
| LRLSTGKDLKLVVRS | 156 | Q8WUN7 | |
| VRLSLTERLGKRKFS | 276 | O75152 | |
| SELGRSRLAKVVKTL | 116 | Q15833 | |
| LRLLSVSSKTLKAEG | 771 | Q96K76 | |
| SLLELIITTKKREAR | 331 | Q9H1D0 | |
| LKVRLSTGKDVRLSA | 151 | Q9HAC8 | |
| KLIDLLRRSGKLEDI | 996 | Q8NDW8 | |
| SLGKESIIEGIKRRI | 156 | Q8N9V7 | |
| LIEKSEGKLSLLVLR | 256 | O95049 | |
| RLIEVTGLARSEIKK | 471 | Q9Y6X8 | |
| TVRTSEVLRKKLGEL | 111 | O43615 | |
| SEEVVKLRISKRSGL | 501 | Q9NNW7 | |
| FLLKTSLKERSRILI | 2191 | Q7Z7G8 | |
| KGRLLKLRAFLTDTL | 286 | O75800 | |
| GLRSKVLRKIEELRT | 381 | Q8N9V3 | |
| ELKRRLGLSTLGELK | 76 | O43399 | |
| GKESIDLVLDRIRKL | 111 | Q9NY65 | |
| GERLSILTKSLLLRR | 806 | Q9UNY4 | |
| RRSLLSGLKLRKSES | 216 | Q8WXH2 | |
| TLLTRGLLKIDRLEK | 526 | A6PVS8 | |
| LLELSRVLGTLLKKG | 386 | Q9UQQ1 |